Drug Watch: Agents in late-stage development for the treatment of pulmonary diseases (March 2009) (PDF)

News
Article

Agents in late-stage development for the treatment of asthma, COPD, and PAH

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
driftwood-stock@adobe.com

Medicare Plans Face Higher Liability From Cap on Out-of-Pocket Drug Costs

Denise Myshko
August 15th 2025
Article

Read More

Remote Care Advancement for Heart Failure, COPD and Diabetes Patients

Remote Care Advancement for Heart Failure, COPD and Diabetes Patients

Briana Contreras
August 15th 2025
Podcast

Listen

Medication Prior Authorization Biggest Daily Challenge for 1 in 5 Prescribers, Survey Says

Medication Prior Authorization Biggest Daily Challenge for 1 in 5 Prescribers, Survey Says

Logan Lutton
August 15th 2025
Article

Read More

FDA Approves First Treatment for Chronic Inflammatory Lung Condition

FDA Approves First Treatment for Chronic Inflammatory Lung Condition

Denise Myshko
August 15th 2025
Article

Read More

Pulmonary Fibrosis Foundation Celebrates 25 Years

Pulmonary Fibrosis Foundation Celebrates 25 Years

Keith Loria
August 15th 2025
Article

Read More

lungs in pinkish color on a blue backgroud | Image credit: ©峰 诸葛 stock.adobe.com

GRI Bio Reports Promising Early Biomarker Data in Ongoing Study of GRI-0621 for IPF

Keith Loria
August 15th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.